4
Changes in Ownership
Aardvark Therapeutics, Inc. Filed Acc 0000950170-25-086147
Options or other derivatives
- Chief Executive Officer acquired 549,534 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Lee Tien-Li · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-06-11 | Grant or award : show line 1 in the form Stock option (right to buy) | +549,534 | 549,534 | D |
Loading xslF345X05/ownership.xml…